UNSPSC 51142301: Nalmefene

This classification denotes an opiate antagonist with the molecular formula C21H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TOV02TDP9I, chemically known as morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, (5.alpha.)- but generally known as nalmefene, which bears US NIH Compound Identifier 4422. European Medicines Agency schedules Nalmefene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09139MIG.

UNSPSC 51142301 Nalmefene (Commodity) covers opioid-antagonist pharmaceuticals, though the single recent state and local opportunity in the market solicits naloxone—a related but distinct opioid reversal agent—alongside drug deactivation systems for community health deployment. Seminole County, Florida's procurement reflects the practical application of this code in public health: acquiring emergency-response medications and supporting infrastructure for overdose intervention and substance-abuse harm reduction. The issuing body mix for this Commodity remains unclear from available recent activity, as the source reflects only one solicitation.

Seminole County, Florida posted the most recent opportunity under this code—an IFB (Invitation for Bid) IFB60459723LAS on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The bid response deadline was July 26, 2023, at 2:00 pm. The contract carries a two-year initial term with a one-year renewal option, a three-month probationary period, and requires vendors to meet E-Verify compliance, drug-free workplace certification, and applicable insurance coverages including workers' compensation, commercial general liability, and professional liability. FEMA potential funding introduces additional federal compliance requirements under the Clean Air Act and Federal Water Pollution Control Act. No explicit small-business or disadvantaged-enterprise set-asides were specified in the solicitation.